ClinicalTrials.govpublic full text
VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
atrial fibrillation, cardiac thrombus, deep vein thrombosis, pulmonary embolism, heart valve replacement (mechanical or biological with af), cardiomyopathy (ischemic or dilated), peripheral vascular disease, anticoagulation, warfarin, vkorc1, cyp2c9, thromboembolism
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 839687
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.